Gilead Sciences Inc
(LTS:0QYQ)
$
89.755
0.23 (0.26%)
Market Cap: 112.32 Bil
Enterprise Value: 132.90 Bil
PE Ratio: 109.56
PB Ratio: 6.12
GF Score: 75/100 Gilead Sciences Inc at Cowen Health Care Conference Transcript
Mar 07, 2023 / 04:10PM GMT
Release Date Price:
$80.78
(-0.14%)
Tyler Martin Van Buren
TD Cowen, Research Division - MD & Senior Equity Research Analyst
Good morning, everyone. Is this slide over? Is there an interference from the speaker? I guess it's just loud.
All right. Well, again, good morning. Tyler Van Buren here, senior biotech analyst at TD Cowen. Thanks again for coming to TD Cowen's 43rd Annual Healthcare Conference. For our next session, we're privileged to have a fireside chat with Gilead. And from Gilead, we have Andy Dickinson, the Chief Financial Officer. Andy, thank you very much for being here.
Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO
Thank you. We're thrilled to be here. I appreciate you having us.
Questions & Answers
Tyler Martin Van Buren
TD Cowen, Research Division - MD & Senior Equity Research Analyst
Of course. And if you guys have any questions, feel free to raise your hand, and we'll do our best to get it asked.
So for an opening question, Andy, maybe you could just start with the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot